|
ニツタ マサユキ
Nitsuta Masayuki
新田 雅之 所属 医学部 医学科（東京女子医科大学病院） 職種 助教 |
|
| 言語種別 | 英語 |
| 発表タイトル | Tert promoter mutation, not H3K27M mutation is a prognostic factor for adult thalamic gliomas |
| 会議名 | The 2021 Society for Neuro-Oncology the 26th Annual Scientific Meeting and Education Day |
| 学会区分 | 国際学会及び海外の学会 |
| 発表形式 | 口頭 |
| 講演区分 | 一般 |
| 発表者・共同発表者 | ◎NITTA Masayuki, MURAGAKI Yoshihiro, KOMORI Takashi, MASUI Kenta, SAITO Taiichi, TSUZUKI SHUNSUKE, FUKUI Atsushi, KORIYAMA Shunichi, ONIDUKA Hiromi, IKUTA Soko, KUWANO Jun, KAWAMATA Takakazu, KUWANO Atsushi |
| 発表年月日 | 2021/11/18 |
| 開催地 （都市, 国名） |
Boston,USA(web) |
| 開催期間 | 2021/11/18～2021/11/21 |
| 学会抄録 | Neuro-Oncology 23(Supplement6),vi118–vi119 2021 |
| 概要 | Purpose
Thalamic diffuse glioma is classified as WHO grade 4 as Diffuse midline glioma, H3K27M mutation if H3K27M mutation was found regardless of its histological findings, but the significance of H3K27M mutation is not clear compared with pediatric cases. We aimed to find genetic prognostic factors in adult thalamic diffuse gliomas. METHODS Pathological diagnosis, genetic abnormalities, and clinical course of adult newly diagnosed thalamic gliomas diagnosed and treated at our institution from July 2007 to March 2020 were retrospectively analyzed. |